Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation

被引：0
|
作者：
机构：
[1] [1,Maiolo, Daniele
[2] Mitola, Stefania
[3] Leali, Daria
[4] Oliviero, Giulio
[5] Ravelli, Cosetta
[6] Bugatti, Antonella
[7] Depero, Laura E.
[8] Presta, Marco
[9] Bergese, Paolo
来源：
Presta, M. (presta@med.unibs.it) | 1600年 / American Chemical Society卷 / 134期
关键词：
45;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Journal article (JA)
引用
下载
收藏
相关论文
共 50 条
  • [31] Ligand independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations
    Lorenzi, MV
    Castagnino, P
    Chen, QO
    Chedid, M
    Miki, T
    FASEB JOURNAL, 1997, 11 (09): : A1331 - A1331
  • [32] VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury
    Wise, Lyn M.
    Stuart, Gabriella S.
    Real, Nicola C.
    Fleming, Stephen B.
    Mercer, Andrew A.
    ADVANCES IN WOUND CARE, 2018, 7 (08) : 283 - 297
  • [33] Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
    Ming-Jer Hsieh
    Hsien-Ta Liu
    Chao-Nin Wang
    Hsiu-Yun Huang
    Yuling Lin
    Yu-Shien Ko
    Jong-Shyan Wang
    Vincent Hung-Shu Chang
    Jong-Hwei S. Pang
    Journal of Molecular Medicine, 2017, 95 : 323 - 333
  • [34] Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity
    Kusaba, Tetsuro
    Okigaki, Mitsuhiko
    Matui, Akihiro
    Murakami, Manabu
    Ishikawa, Kazuhiko
    Kimura, Taikou
    Sonomura, Kazuhiro
    Adachi, Yasushi
    Shibuya, Masabumi
    Shirayama, Takeshi
    Tanda, Shuji
    Hatta, Tsuguru
    Sasaki, Susumu
    Mori, Yasukiyo
    Matsubara, Hiroaki
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (45) : 19308 - 19313
  • [35] Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents
    Yoshiji, Hitoshi
    Noguchi, Ryuichi
    Ikenaka, Yasuhide
    Kaji, Kosuke
    Shirai, Yusaku
    Aihara, Yosuke
    Yamao, Junichi
    Toyohara, Masahisa
    Mitoro, Akira
    Sawai, Masayoshi
    Yoshida, Motoyuki
    Morioka, Chie
    Fujimoto, Masao
    Uemura, Masahito
    Kawaratani, Hideto
    Tsujimoto, Tatsuhiro
    Fukui, Hiroshi
    ONCOLOGY LETTERS, 2011, 2 (01) : 69 - 73
  • [36] Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy
    Witte, L
    Hicklin, DJ
    Zhu, ZP
    Pytowski, B
    Kotanides, H
    Rockwell, P
    Böhlen, P
    CANCER AND METASTASIS REVIEWS, 1998, 17 (02) : 155 - 161
  • [37] Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy
    Larry Witte
    Daniel J. Hicklin
    Zhenping Zhu
    Bronislaw Pytowski
    Helen Kotanides
    Patricia Rockwell
    Peter Böhlen
    Cancer and Metastasis Reviews, 1998, 17 : 155 - 161
  • [38] Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9
    Zou, Jiang
    Wang, Nian
    Liu, Manting
    Bai, Yongping
    Wang, Hao
    Liu, Ke
    Zhang, Huali
    Xiao, Xianzhong
    Wang, Kangkai
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (05) : 2692 - 2705
  • [39] Does nulliparity modulate the expression levels of main pro-angiogenic factors: VEGF, VEGFR2, Akt and ERK2, in the mouse ovary?
    Di Luigi, Gianluca
    Cecconi, Sandra
    Castellucci, Annalisa
    Rossi, Gianna
    Cellini, Valerio
    Carta, Gaspare
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 138 - 138
  • [40] The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production
    Monika Litwin
    Agata Radwańska
    Maria Paprocka
    Claudine Kieda
    Tadeusz Dobosz
    Wojciech Witkiewicz
    Dagmara Baczyńska
    Molecular and Cellular Biochemistry, 2015, 410 : 131 - 142
12345